| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -6.9e-05 | 1 |